Blaschko lines and other patterns of cutaneous mosaicism

Clinics in Dermatology

Volumn 29, Issue 2, 2011, Pages 205-225

  Molho Pessach, Vered ^a   Schaffer, Julie V ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOME MOSAICISM; BLASCHKO LINE; CUTANEOUS MOSAICISM; DIFFERENTIAL DIAGNOSIS; DOMINANT INHERITANCE; EPIGENETICS; GENE MUTATION; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; PRIORITY JOURNAL; SEX CHROMOSOME MOSAICISM; SKIN EXAMINATION; SKIN MANIFESTATION; X CHROMOSOME LINKED DISORDER;

CHROMOSOME DISORDERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MOSAICISM; SKIN DISEASES;

EID: 79952396239     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.09.012     Document Type: Article

References (82)

1. Blaschko A. Die Nervenverteilung in der Haut in ihrer Beziezehung zu den Erkrankungen der Haut 1901.
2. Happle R., Assim A. The lines of Blaschko on the head and neck. J Am Acad Dermatol 2001, 44:612-615.
3. Happle R. Genetische Bedeutung der Blaschoschen Linien. Z Hautkr 1977, 52:935-944.
4. Happle R. Mosaicism in human skin: Understanding the pattern and mechanisms. Arch Dermatol 1993, 129:1460-1470.
5. Lyon M.F. X-chromosome inactivation. Curr Biol 1999, 9:235-237.
6. Sun B.K., Tsao H. X-chromosome inactivation and skin disease. J Invest Dermatol 2008, 128:2753-2759.
7. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404.
8. Cordaux R., Batzer M.A. The impact of retrotransposons on human genome evolution. Nat Rev Genet 2009, 10:691-703.
9. Whitelaw E., Martin D.I.K. Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 2001, 27:361-364.
10. Happle R. Monoallelic expression on autosomes may explain an unusual heritable form of pigmentary mosaicism: a historical case revisited. Clin Exp Dermatol 2009, 34:834-837.
11. Happle R. New aspects of cutaneous mosaicism. Dohi memorial lecture. J Dermatol 2002, 29:681-692.
12. Moss C. Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines. Am J Med Genet 1999, 331:1408-1415.
13. Paller A.S. Piecing together the puzzle of cutaneous mosaicism. J Clin Invest 2004, 114:1407-1409.
14. Moss C., Larkins S., Stacey M., et al. Epidermal mosaicism and Blaschko's lines. J Med Genet 1993, 30:752-755.
15. Paller A.S., Syder A.J., Chan Y.M., et al. Genetic and clinical mosaicism in a type of epidermal nevus. N Engl J Med 1994, 1408-1415.
16. Taibjee S.M., Hall D., Balderson D., et al. Keratinocyte cytogenetics in 10 patients with pigmentary mosaicism: identification of one case of trisomy 20 mosaicism confined to keratinocytes. Clin Exp Dermatol 2009, 34:823-829.
17. Happle R. Pigmentary patterns associated with human mosaicism: a proposed classification. Eur J Dermatol 1993, 3:170-174.
18. Rieger E., Kofler R., Borkenstein M., et al. Melanotic macules following Blaschko's lines in McCune-Albright syndrome. Br J Dermatol 1994, 130:215-220.
19. Lumbroso S., Paris F., Sultan C. Activating Gs alpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome-a European Collaborative Study. J Clin Endocrinol Metab 2004, 89:2107-2113.
20. Torrelo A., Baselga E., Nagore E., et al. Delineation of the various shapes and patterns of nevi. Eur J Dermatol 2005, 15:439-450.
21. Findlay G.H., Moores P.P. Pigment anomalies of the skin in human chimaera: their relation to systematized naevi. Br J Dermatol 1980, 103:489-498.
22. Lipsker D., Flory E., Wiesel M.L., et al. Between light and dark, the chimera comes out. Arch Dermatol 2008, 144:327-330.
23. Happle R. Phylloid hypomelanosis and mosaic trisomy 13: a new etiologically defined neurocutaneous syndrome. Hautarzt 2001, 52:3-5.
24. Gonzalez-Ensenat M.A., Vicente A., Poo P., et al. Phylloid hypomelanosis and mosaic partial trisomy 13: two cases that provide further evidence of a distinct clinicogenetic entity. Arch Dermatol 2009, 145:576-578.
25. Hansen L.K., Brandrup F., Rasmussen K. Pigmentary mosaicism with mosaic chromosome 5p tetrasomy. Br J Dermatol 2003, 149:414-416.
26. Hwang S.W., Cho K.J., Kang J.H., et al. A case of hypermelanosis in a phylloid pattern. J Am Acad Dermatol 2009, 60:697-700.
27. Konig A., Happle R., Bornholdt E., et al. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet 2000, 90:339-346.
28. Konig A., Happle R., Fink-Puches, et al. A novel missense mutation of NSDHL in an unusual case of CHILD syndrome showing bilateral, almost symmetric involvement. J Am Acad Dermatol 2002, 46:594-596.
29. Happle R. X-chromosome inactivation: role in skin disease expression. Acta Paediatr 2006, 95:16-23.
30. Paller A.S. Wnt signaling in focal dermal hypoplasia. Nat Genet 2007, 39:820-821.
31. Tsubota A., Akiyama M., Sakai K., et al. Keratin 1 gene mutation detected in epidermal nevus with epidermolytic hyperkeratosis. J Invest Dermatol 2007, 127:1371-1374.
32. Sakuntabhai A., Dhitavat J., Burge S., et al. Mosaicism for ATP2A2 mutations causes segmental Darier's disease. J Invest Dermatol 2000, 115:1144-1147.
33. Tinscher S., Naumann I., Stegmann E., et al. Segmental neurofibromatosis is caused by somatic mutations of neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 2000, 8:455-459.
34. Munro C.S., Wilkie A.O. Epidermal mosaicism producing localized acne: somatic mutation in FGFR2. Lancet 1998, 352:704-705.
35. Melnik B.C., Vakilzadeh F., Aslanidis C., et al. Unilateral segmental acneiform naevus: a model disorder towards understanding fibroblast growth factor receptor 2 function in acne?. Br J Dermatol 2008, 158:1397-1399.
36. Hafner C., van Oers J.M.M., Vogt T., et al. Mosaicism of activating of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 2006, 116(33):744-748.
37. Garcia-Vargas A., Hafner C., Perez Rodrigez A.G., et al. An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation. Am J Med Genet 2008, 146A:2275-2279.
38. Terrinoni A., Puddu P., Didona B., et al. A mutation in the V1 domain of K16 is responsible for unilateral palmoplantar verrucous nevus. J Invest Dermatol 2000, 114:1136-1140.
39. Limaye N., Wouters V., Uebelhoer M., et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 2009, 41:118-124.
40. Poblete-Gutierrez P., Wiederholt T., Konig A., et al. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 2004, 114:1407-1409.
41. Maertens O., De Schepper S., Vandesompele J., et al. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet 2007, 81:243-251.
42. Brems H., Chmara M., Sahbatou M., et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007, 39:1120-1126.
43. Caux F., Plauchu H., Chibon F., et al. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet 2007, 15:767-773.
44. Brouillard P., Boon L.M., Mulliken J.B., et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet 2002, 70:866-874.
45. Ritzmann S., Hanneken S., Neumann N.J., et al. Type 2 segmental manifestation of cutaneous leiomyomatosis in four unrelated women with additional uterine leiomyomas (Reed's syndrome). Dermatology 2006, 212:84-87.
46. Happle R. Type 2 segmental trichoepitheliomatosis: a genetic concept that may explain congenital multiple trichoepitheliomas in the lines of Blaschko. Pediatr Dermatol 2007, 24:448-449.
47. Happle R. Somatic recombination may explain linear porokeratosis associated with disseminated superficial actinic porokeratosis. Am J Med Genet 1991, 39:237.
48. Happle R. What is paradominant inheritance?. J Med Genet 2009, 46:648.
49. Prigent F., Cavelier-Balloy B., Lemarchand-Venencie F., et al. Linear lichen nitidus. Ann Dermatol Venereol 1989, 116:814-815.
50. Ozkaya-Bayazit E., Baykal C. Trimethoprim-induced linear fixed drug eruption. Br J Dermatol 1997, 137:1028.1-1029.1.
51. Kikuchi A., Okamoto S., Takahashi S. Linear chronic graft-versus-host-disease. J Am Acad Dermatol 1997, 37:1004-1006.
52. Krasowska D., Schwartz R.A., Lecewicz-Torun B. Generalized lichenoid drug eruption following Blaschko lines. Int J Dermatol 2001, 40:774-776.
53. Danarti R., Bittar M., Happle R., et al. Linear atrophoderma of Moulin: postulation of mosaicism for a predisposing gene. J Acad Dermatol 2003, 49:492-498.
54. Hladik F., Jurecka W., Hayek B., et al. Atopic dermatitis with increased severity along a line of Blaschko. J Am Acad Dermatol 2005, 53:S221-224.
55. Gaitanis G., Nomikos K., Chaniotakis I., et al. Linear cutaneous lupus erythematosus: a subset of childhood cutaneous lupus erythematosus. Lupus 2009, 18:759-761.
56. Weibel L., Harper J.I. Linear morphoea follows Blaschko's lines. Br J Dermatol 2008, 159:175-181.
57. Patrizi A., Neri I., Fiorentini C., et al. Lichen striatus: clinical and laboratory features of 115 children. Pediatr Dermatol 2004, 21:197-204.
58. Taniguchi Abagge K., Parolin Marinoni L., Giraldi S., et al. Lichen striatus: description of 89 cases in children. Pediatr Dermatol 2004, 21:440-443.
59. Lee H.J., Kang W.H., Hann S.K. Acquired Blaschko dermatitis: acquired relapsing self-healing Blaschko dermatitis. J Dermatol 1996, 23:639-642.
60. Keegan B.R., Kamino H. Fangman W, et al. "Pediatric blaschkitis": expanding the spectrum of childhood acquired Blaschko-linear dermatoses. Pediatr Dermatol 2007, 24:621-627.
61. Happle R. Linear psoriasis and ILVEN: is lumping or splitting appropriate. Dermatology 2006, 212:101-102.
62. Lee S.H., Rogers M. Inflammatory linear verrucous epidermal naevi: a review of 23 cases. Australas J Dermatol 2001, 42:252-256.
63. Goddard D.S., Rogers M., Frieden I.J., et al. Widespread porokeratotic adnexal ostial nevus: clinical features and proposal of a new name unifying porokeratotic eccrine ostial and dermal duct nevus and porokeratotic eccrine and hair follicle nevus. J Am Acad Dermatol 2009, 61:1060.e1-1060.e14.
64. Taibjee S.M., Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br J Dermatol 2004, 151:269-282.
65. Nehal K.S., Pebenito R., Orlow S.J. Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol 1996, 132:1167-1170.
66. Küster W., König A. Hypomelanosis of Ito: no entity, but a cutaneous sign of mosaicism. Am J Med Genet 1999, 85:346-350.
67. Ruiz-Maldonado R., Toussaint S., Tamayo L., et al. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992, 9:1-10.
68. Vanderhooft S.L., Francis J.S., Pagon R.A., et al. Prevalence of hypopigmented macules in a healthy population. J Pediatr 1996, 1229:355-361.
69. Lee H.S., Chun Y.S., Hann S.K. Nevus depigmentosus: clinical features and histopathological characteristics in 67 patients. J Am Acad Dermatol 1999, 40:21-26.
70. Kim S.K., Kang H.Y., Lee E.S., et al. Clinical and histopathologic characteristics of nevus depigmentosus. J Am Acad Dermatol 2006, 55:423-428.
71. Xu A.E., Huang B., Li Y.W., et al. Clinical, histopathological and ultrastructural characteristics of naevus depigmentosus. Clin Exp Dermatol 2008, 33:400-405.
72. Karabiber H., Sasmaz S., Turanli G., et al. Prevalence of hypopigmented maculae and café-au-lait spots in idiopathic epileptic and healthy children. J Child Neurol 2002, 17:57-59.
73. Lombillo V.A., Sybert V.P. Mosaicism in cutaneous pigmentation. Curr Opin Ped 2005, 17:494-500.
74. Di Lernia V. Linear and whorled hypermelanosis. Pediatr Dermatol 2007, 24:205-210.
75. Anderson R.C., Zinn A.R., Kim J., et al. X-linked reticulate pigmentary disorder with systemic manifestations: report of a third family and literature review. Pediatr Dermatol 2005, 22:122-126.
76. Cambiaghi S., Restano L., Pääkkönen K., et al. Clinical findings in mosaic carriers of hypohidrotic ectodermal dysplasia. Arch Dermatol 2000, 136:217-224.
77. Kosaki K., Shimasaki N., Fukushima H., et al. Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency. Am J Hum Genet 2001, 69:664-665.
78. Loomis C.A. Linear hypopigmentation and hyperpigmentation including mosaicism. Semin Cutan Med Surg 1997, 16:44-53.
79. Iorizzo M., Piraccini B.M., Tosti A. Heterochromia of the scalp hair following Blaschko lines. Pediatr Dermatol 2007, 24:69-70.
80. Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol 1999, 41:143-161.
81. Spano M.A., Frei H., Wurgler F.E., et al. Recombinogenic activity of four compounds in the standard and high bioactivation crosses of Drosophila melanogaster in the wing spot test. Mutagenesis 2001, 16:285-294.
82. Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol 2005, 141:385-388.